Analysis of the HIV Vaccine Trials Network 702 Phase 2b–3 HIV-1 Vaccine Trial in South Africa Assessing RV144 Antibody and T-Cell Correlates of HIV-1 Acquisition RiskZoe Moodie, M. Juliana McElrath, Sheetal Sawant et al.|Zenodo (CERN European Organization for Nuclear Research)|2022Cited by 0